MedTrace Logo

Study With Two Coenzyme Q10 Products

NCT06736366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-12-05

No results posted yet for this study

Summary

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products

Conditions

  • Coenzyme Q Deficiency

Interventions

DIETARY_SUPPLEMENT

Dietary supplement - Active comparator

Single dose intervention with Standard product Coenzyme Q10 (ubiquinone); 2 capsules - 100 mg total coenzyme Q10

DIETARY_SUPPLEMENT

Dietary supplement - Experimental product

Single dose intervention with Experimental product; BMT® coenzyme Q10; 2 capsules - 100 mg total coenzyme Q10

Sponsors & Collaborators

  • Biostile d.o.o.

    collaborator UNKNOWN

  • QFarm s.r.l.

    collaborator UNKNOWN

  • University of Primorska

    lead OTHER

Principal Investigators

  • Ana Petelin, phD · University of Primorska, Faculty of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-05
Primary Completion
2024-12-16
Completion
2025-06-30

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06736366 on ClinicalTrials.gov